---
title: 'Pacemaker Versus Defibrillator Therapy in Patients Eligible for Cardiac Resynchronisation
  Therapy: Evidence from the German Device Registry'
date: '2025-02-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/40004671/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250226171103&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Background: According to current guidelines, cardiac resynchronisation
  therapy (CRT) is recommended in patients with significantly impaired left ventricular
  systolic function and left bundle branch block. However, the decision between pacemaker
  (CRT-P) and defibrillator (CRT-D) in patients eligible for CRT remains a matter
  of debate. Register data have shown a higher all-cause mortality in CRT-P in comparison
  to patients with a CRT-D. Here, we investigated clinical determinants of the ...'
disable_comments: true
---
Background: According to current guidelines, cardiac resynchronisation therapy (CRT) is recommended in patients with significantly impaired left ventricular systolic function and left bundle branch block. However, the decision between pacemaker (CRT-P) and defibrillator (CRT-D) in patients eligible for CRT remains a matter of debate. Register data have shown a higher all-cause mortality in CRT-P in comparison to patients with a CRT-D. Here, we investigated clinical determinants of the ...